0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538

Global Cardiac Assist Devices Market Forecast up to 2025

Published Date: March 2019
|
Report Code: INFO-Othe-239
Home | Category |Health |Health Conditions |Heart & Hypertension
Global Cardiac Assist Devices Market Forecast up to 2025

Global Cardiac Assist Devices Market Forecast up to 2025

Code: INFO-Othe-239
Report
March 2019
88 Pages
Infoholic Research
Region: North America, Europe, Asia Pacific,
Description
Table of Content
Tables & Figures

This market research report includes a detailed segmentation of the global cardiac assist devices market by product (Intra-Aortic Balloon Pump and Ventricular Assist Devices {Left Ventricular Assist Devices [LVAD], Right Ventricular Assist Devices [RVAD], and Biventricular Assist Devices [BIVAD]), and by region (North America, Europe, Asia Pacific, and Rest of the World).


Overview of the Global Cardiac Assist Devices Market Research

Infoholic’s market research report predicts that the global cardiac assist devices market will grow at a CAGR of 11.6% during the forecast period. The market has witnessed steady growth in the past few years and the advancement in technology coupled with the introduction of novel products have augmented the acceptance of heart assist devices in the market. The market is fueled by upsurge in the incidence of heart failure, growing elderly population, and shortage of heart donors for transplantation.

The market continues to grow and the devices are most widely used for the functioning of heart in case of failure and weakened heart patients. The field is getting revolutionized with the availability of improved technology. The key market players are focusing towards approvals, new product launches, and targeting towards end-user’s perspective. The market generates the revenue from the key players operating in this field and some of them includes Abbott Laboratories, Berlin Heart GmbH, Maquet GmbH (Getinge AB), SynCardia Systems, LLC, and ReliantHeart, Inc.
According to Infoholic Research analysis, North America accounted for the largest share of the global cardiac assist devices market in 2018 and is expected to remain the leading region in terms of value during the forecast period.
According to American Heart Association, an estimated 92.1 million population in US have at least one type of CVD and by 2030 it is projected that close to 44% of the US adult population to have some form of CVD. Increasing incidence of cardiovascular diseases, promising reimbursement policies, presence of dominant vendors, and accessibility of advanced technologies will increase the demand and adoption of the cardiac assist devices in the region.


Europe is the second largest region in terms of cardiac assist devices market. Cardiovascular disease (CVD) causes 3.9 million deaths and over 1.8 million deaths in EU countries. In UK alone, around 60,000 new cases of advanced chronic heart failure are diagnosed every year out of which 40% die within a year.
Asia Pacific is expected to grow at mid-double digit CAGR during the forecast period, owing to factors such as growing healthcare expenditure, high prevalence of lifestyle related disorders, and increasing acceptance of advanced technologies in the market.


By Product:
• Intra-Aortic Balloon Pump (IABP)
• Ventricular Assist Devices (VAD)
o Left Ventricular Assist Devices (LVAD)
o Right Ventricular Assist Devices (RVAD)
o Biventricular Assist Devices (BIVAD)
• Total Artificial Heart (TAH)
In 2018, the ventricular assist devices segment occupied the largest share and is expected to grow at mid-double digit CAGR during the forecast period. The ventricular assist devices market is further segmented into left ventricular assist devices, right ventricular assist devices, and biventricular assist devices. Among these, left ventricular assist devices occupied a major share and is expected to grow at high CAGR during the forecast period. Increasing number of patients suffering from last-stage heart failure, advancements in technology leading to better effectiveness & high survival rate, and decreased risk of the devices makes the segment the most common among other VAD devices.

By Regions:
• North America
• Europe
• Asia Pacific
• Rest of the World

The market is dominated by North America, followed by Europe and Asia Pacific. The US occupied the major share of the North American market due to the presence of key vendors and obtainability of advanced technologies.
Cardiac Assist Devices Market Research Competitive Analysis – The global cardiac assist devices market has massive growth opportunities in both developed and developing regions. The upgradation and advancements of devices will increase the competition among the market players. Many companies are concentrating on new approvals, funding, and development of new products related to cardiac assist device because of the increase in implantable procedures. For instance, Teleflex announced FDA approval for intra-aortic balloon pump in 2017. The AC3 Optimus device delivers intra-aortic balloon pump therapy to assist in pumping blood.


In October 2018, FDA approved HeartMate 3 left ventricular assist device developed by Abbott, as a destination therapy for patients with advanced heart failure. In January 2018, Canada regulatory body issued a Class IV License with conditions to HeartMate 3 Left Ventricular Assist System (LVAS) developed by Thoratec Corporation. BiVACOR Pty Ltd is developing a rotary Total Artificial Heart (TAH) device and its initiative is funded by OneVentures, a venture capital firm and the Federal Government of Australia. In addition, other leading vendors are focusing in investing huge on research and development activities to develop new products to obtain high share in the market.

Key vendors:

• Abbott Laboratories
• Berlin Heart GmbH
• Maquet GmbH (Getinge AB)
• ReliantHeart, Inc.
• SynCardia Systems, LLC
• ABIOMED, Inc.
• BiVACOR, Inc.
• Medtronic plc
• XENIOS AG (Fresenius Medical Care AG & Co. KGaA)
• Teleflex Incorporated
• Carmat SA
• Calon Cardio-Technology Ltd.
• LivaNova, PLC

Key competitive facts –

• The market is highly competitive with all the players competing to gain market share. Intense competition, rapid advancements in technology, frequent changes in government policies, and the prices of devices are some of the key factors that confront the market.
• The requirement of high initial investment, implementation, and maintenance cost in the market are also limiting the entry of new players.
Benefits – The report provides complete details about the current and forecast market size of every type of cardiac assist devices and market values by region. Through this report, the key stakeholders in the cardiac assist devices ecosystem can also know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives towards the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals and to analyze before investing or expanding the business in this market.

Key Takeaways:


• Understanding the potential market opportunity with precise market size and forecast data
• Detailed market analysis focusing on the growth of cardiac assist devices industry
• Factors influencing the growth of cardiac assist devices market
• In-depth competitive analysis of dominant and pureplay vendors
• Prediction analysis of cardiac assist devices industry in both developed and developing regions
• Key insights related to major segments of the cardiac assist devices market
• Latest market trend analysis impacting the buying behavior of the consumers


"

"Table of Contents
1 INDUSTRY OUTLOOK 8
1.1 Industry Overview 8
1.1.1 Geography 8
1.1.2 Medical Technologies 9
1.1.3 Industry Trends 11
1.2 Total Addressable Market 12
2 Report Outline 13
2.1 Report Scope 13
2.2 Report Summary 13
2.3 Research Methodology 14
2.4 Report Assumptions 14
3 Market Snapshot 16
3.1 Market Definition – Infoholic Research 16
3.2 Device Benefits 16
3.3 Segmented Addressable Market (SAM) 16
3.4 Trends of the Cardiac Assist Devices Market 17
3.5 Related Markets 18
3.5.1 Interventional Cardiology 18
3.5.2 Angioplasty 18
3.5.3 Stents 18
4 Market Outlook 20
4.1 Reimbursement Codes 20
4.2 Regulatory Status 23
4.3 Clinical Trials 24
4.4 Market Segmentation 25
4.5 PEST Analysis 25
4.6 Porter 5(Five) Forces 26
5 Market Characteristics 28
5.1 DRO – Global Cardiac Assist Devices Market Dynamics 28
5.1.1 Drivers 29
5.1.1.1 Increasing incidence of cardiovascular device across the globe 29
5.1.1.2 Lack of heart donors globally 29
5.1.1.3 Increasing aged population 30
5.1.2 Opportunities 30
5.1.2.1 Increase in healthcare spending and demand for improved treatment in developing economies 30
5.1.2.2 Robust pipeline of products 30
5.1.3 Restraints 31
5.1.3.1 High cost of the cardiac assist device 31
5.1.3.2 Stringent regulatory policies 31
5.2 DRO – Impact Analysis 32
5.3 Key Stakeholders 32
6 Products: Market Size and Analysis 34
6.1 Overview 34
6.2 Intra-Aortic Balloon Pumps 35
6.3 Ventricular Assist Devices 36
6.3.1 Left Ventricular Assist Devices 38
6.3.2 Right Ventricular Assist Devices 39
6.3.3 Biventricular Assist Device (BIVAD) 40
6.4 Total Artificial Heart 41
7 Regions: Market Size and Analysis 43
7.1 Overview 43
7.2 North America 44
7.3 Europe 46
7.4 Asia Pacific 47
7.5 Rest of the World 49
8 Competitive Landscape 51
8.1 Overview 51
9 Vendor Profiles 54
9.1 Abbott Laboratories 54
9.1.1 Overview 54
9.1.2 Business Units 57
9.1.3 Geographic Presence 58
9.1.4 Business Focus 59
9.1.5 SWOT Analysis 59
9.1.6 Business Strategies 60
9.2 Berlin Heart GmbH 61
9.2.1 Overview 61
9.2.2 Business Focus 61
9.2.3 SWOT Analysis 62
9.2.4 Business Strategies 62
9.3 Maquet GmbH (Getinge AB) 63
9.3.1 Overview 63
9.3.2 Business Units 65
9.3.3 Geographic Revenue 66
9.3.4 Business Focus 66
9.3.5 SWOT Analysis 67
9.3.6 Business Strategies 67
9.4 ReliantHeart, Inc. 68
9.4.1 Overview 68
9.4.2 Business Focus 69
9.4.3 SWOT Analysis 69
9.4.4 Business Strategies 70
9.5 SynCardia Systems, LLC 70
9.5.1 Overview 70
9.5.2 Business Focus 71
9.5.3 SWOT Analysis 72
9.5.4 Business Strategies 72
10 Companies to Watch For 74
10.1 ABIOMED, Inc. 74
10.1.1 Overview 74
10.2 Medtronic plc 76
10.2.1 Overview 76
10.3 BiVACOR, Inc. 79
10.3.1 Overview 79
10.4 XENIOS AG (Fresenius Medical Care AG & Co. KGaA) 80
10.4.1 Overview 80
10.5 Teleflex Incorporated 81
10.5.1 Overview 81
10.6 Calon Cardio-Technology Ltd. 83
10.6.1 Overview 83
10.7 Carmat SA 84
10.7.1 Overview 84
10.8 LivaNova, PLC 85
10.8.1 Overview 85
11 Annexure 87
11.1 Abbreviations 87


"

List of Tables & Figures:

TABLE 1 REIMBURSEMENT CODES 20
ICD-10-CM DIAGNOSIS CODES THAT SUPPORT COVERAGE CRITERIA 22
TABLE 2 REGULATORY STATUS OF CARDIAC ASSIST DEVICES 23
TABLE 3 CLINICAL TRIALS 24
TABLE 4 GLOBAL CARDIAC ASSIST DEVICES MARKET REVENUE BY REGIONS, 2018–2025 ($MILLION) 44
TABLE 5 OTHER PROMINENT VENDORS OF CARDIAC ASSIST DEVICES MARKET 52
TABLE 6 ABBOTT LABORATORIES: PRODUCT OFFERINGS 54
TABLE 7 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 54
TABLE 8 BERLIN HEART GMBH: PRODUCT OFFERINGS 61
TABLE 9 BERLIN HEART GMBH: RECENT DEVELOPMENTS 61
TABLE 10 MAQUET GMBH (GETINGE AB): OFFERINGS 63
TABLE 11 MAQUET GMBH (GETINGE AB): RECENT DEVELOPMENTS 63
TABLE 12 RELIANTHEART, INC.: OFFERINGS 68
TABLE 13 RELIANTHEART, INC.: RECENT DEVELOPMENTS 68
TABLE 14 SYNCARDIA SYSTEMS, LLC: PRODUCT OFFERINGS 71
TABLE 15 SYNCARDIA SYSTEMS, LLC: RECENT DEVELOPMENTS 71
TABLE 16 ABIOMED, INC.: SNAPSHOT 74
TABLE 17 ABIOMED, INC.: RECENT DEVELOPMENTS 74
TABLE 18 MEDTRONIC PLC: SNAPSHOT 76
TABLE 19 MEDTRONIC PLC: RECENT DEVELOPMENTS 77
TABLE 20 BIVACOR, INC.: SNAPSHOT 79
TABLE 21 XENIOS AG (FRESENIUS MEDICAL CARE AG & CO. KGAA): SNAPSHOT 80
TABLE 22 XENIOS AG (FRESENIUS MEDICAL CARE AG & CO. KGAA): RECENT DEVELOPMENTS 80
TABLE 23 TELEFLEX INCORPORATED: SNAPSHOT 81
TABLE 24 TELEFLEX INCORPORATED: RECENT DEVELOPMENTS 81
TABLE 25 CALON CARDIO-TECHNOLOGY LTD.: SNAPSHOT 83
TABLE 26 CALON CARDIO-TECHNOLOGY LTD.: RECENT DEVELOPMENTS 84
TABLE 27 CARMAT SA: SNAPSHOT 84
TABLE 28 CARMAT SA: RECENT DEVELOPMENTS 84
TABLE 29 LIVANOVA, PLC.: SNAPSHOT 85
TABLE 30 LIVANOVA, PLC: RECENT DEVELOPMENTS 85


"
"CHARTS
CHART 1 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION 9
CHART 2 RESEARCH METHODOLOGY OF GLOBAL CARDIAC ASSIST DEVICES MARKET 14
CHART 3 GLOBAL CARDIAC ASSIST DEVICES MARKET REVENUE, 2018–2025 ($MILLION) 17
CHART 4 SEGMENTATION OF GLOBAL CARDIAC ASSIST DEVICES MARKET 25
CHART 5 PEST ANALYSIS OF GLOBAL CARDIAC ASSIST DEVICES MARKET 25
CHART 6 PORTER 5 FORCES ON GLOBAL CARDIAC ASSIST DEVICES MARKET 26
CHART 7 MARKET DYNAMICS – DRO ANALYSIS 28
CHART 8 DRO – IMPACT ANALYSIS OF GLOBAL CARDIAC ASSIST DEVICES MARKET 32
CHART 9 KEY STAKEHOLDERS 32
CHART 10 GLOBAL CARDIAC ASSIST DEVICES MARKET BY PRODUCT SEGMENTATION, 2018 (%) 34
CHART 11 GLOBAL CARDIAC ASSIST DEVICES MARKET BY PRODUCT SEGMENTATION, 2025 (%) 35
CHART 12 GLOBAL INTRA-AORTIC BALLOON PUMP MARKET FORECAST, 2018–2025 ($MILLION) 35
CHART 13 GLOBAL VENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018–2025 ($MILLION) 36
CHART 14 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY PRODUCT TYPE SEGMENTATION, 2018 (%) 37
CHART 15 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY PRODUCT TYPE SEGMENTATION, 2025 (%) 38
CHART 16 GLOBAL LEFT VENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018–2025 ($MILLION) 39
CHART 17 GLOBAL RIGHT VENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018–2025 ($MILLION) 40
CHART 18 GLOBAL BIVENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018–2025 ($MILLION) 41
CHART 19 GLOBAL TOTAL ARTIFICIAL HEART MARKET FORECAST, 2018–2025 ($MILLION) 42
CHART 20 GLOBAL CARDIAC ASSIST DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2018 (%) 43
CHART 21 GLOBAL CARDIAC ASSIST DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2025 (%) 43
CHART 22 CARDIAC ASSIST DEVICES MARKET REVENUE IN NORTH AMERICA, 2018–2025 ($MILLION) 45
CHART 23 CARDIAC ASSIST DEVICES MARKET REVENUE IN EUROPE, 2018–2025 ($MILLION) 47
CHART 24 CARDIAC ASSIST DEVICES MARKET REVENUE IN ASIA PACIFIC, 2018–2025 ($MILLION) 49
CHART 25 CARDIAC ASSIST DEVICES MARKET REVENUE IN REST OF THE WORLD, 2018–2025 ($MILLION) 50
CHART 26 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT 56
CHART 27 ABBOTT LABORATORIES: BUSINESS UNITS 57
CHART 28 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE 58
CHART 29 ABBOTT LABORATORIES: SWOT ANALYSIS 59
CHART 30 BERLIN HEART GMBH: SWOT ANALYSIS 62
CHART 31 MAQUET GMBH (GETINGE AB): OVERVIEW SNAPSHOT 64
CHART 32 MAQUET GMBH (GETINGE AB): BUSINESS UNITS REVENUE 65
CHART 33 MAQUET GMBH (GETINGE AB): GEOGRAPHICAL REVENUE 66
CHART 34 MAQUET GMBH (GETINGE GROUP): SWOT ANALYSIS 67
CHART 35 RELIANTHEART, INC.: SWOT ANALYSIS 69
CHART 36 SYNCARDIA SYSTEMS, LLC: SWOT ANALYSIS 72

 

"

This market research report includes a detailed segmentation of the global cardiac assist devices market by product (Intra-Aortic Balloon Pump and Ventricular Assist Devices {Left Ventricular Assist Devices [LVAD], Right Ventricular Assist Devices [RVAD], and Biventricular Assist Devices [BIVAD]), and by region (North America, Europe, Asia Pacific, and Rest of the World).


Overview of the Global Cardiac Assist Devices Market Research

Infoholic’s market research report predicts that the global cardiac assist devices market will grow at a CAGR of 11.6% during the forecast period. The market has witnessed steady growth in the past few years and the advancement in technology coupled with the introduction of novel products have augmented the acceptance of heart assist devices in the market. The market is fueled by upsurge in the incidence of heart failure, growing elderly population, and shortage of heart donors for transplantation.

The market continues to grow and the devices are most widely used for the functioning of heart in case of failure and weakened heart patients. The field is getting revolutionized with the availability of improved technology. The key market players are focusing towards approvals, new product launches, and targeting towards end-user’s perspective. The market generates the revenue from the key players operating in this field and some of them includes Abbott Laboratories, Berlin Heart GmbH, Maquet GmbH (Getinge AB), SynCardia Systems, LLC, and ReliantHeart, Inc.
According to Infoholic Research analysis, North America accounted for the largest share of the global cardiac assist devices market in 2018 and is expected to remain the leading region in terms of value during the forecast period.
According to American Heart Association, an estimated 92.1 million population in US have at least one type of CVD and by 2030 it is projected that close to 44% of the US adult population to have some form of CVD. Increasing incidence of cardiovascular diseases, promising reimbursement policies, presence of dominant vendors, and accessibility of advanced technologies will increase the demand and adoption of the cardiac assist devices in the region.


Europe is the second largest region in terms of cardiac assist devices market. Cardiovascular disease (CVD) causes 3.9 million deaths and over 1.8 million deaths in EU countries. In UK alone, around 60,000 new cases of advanced chronic heart failure are diagnosed every year out of which 40% die within a year.
Asia Pacific is expected to grow at mid-double digit CAGR during the forecast period, owing to factors such as growing healthcare expenditure, high prevalence of lifestyle related disorders, and increasing acceptance of advanced technologies in the market.


By Product:
• Intra-Aortic Balloon Pump (IABP)
• Ventricular Assist Devices (VAD)
o Left Ventricular Assist Devices (LVAD)
o Right Ventricular Assist Devices (RVAD)
o Biventricular Assist Devices (BIVAD)
• Total Artificial Heart (TAH)
In 2018, the ventricular assist devices segment occupied the largest share and is expected to grow at mid-double digit CAGR during the forecast period. The ventricular assist devices market is further segmented into left ventricular assist devices, right ventricular assist devices, and biventricular assist devices. Among these, left ventricular assist devices occupied a major share and is expected to grow at high CAGR during the forecast period. Increasing number of patients suffering from last-stage heart failure, advancements in technology leading to better effectiveness & high survival rate, and decreased risk of the devices makes the segment the most common among other VAD devices.

By Regions:
• North America
• Europe
• Asia Pacific
• Rest of the World

The market is dominated by North America, followed by Europe and Asia Pacific. The US occupied the major share of the North American market due to the presence of key vendors and obtainability of advanced technologies.
Cardiac Assist Devices Market Research Competitive Analysis – The global cardiac assist devices market has massive growth opportunities in both developed and developing regions. The upgradation and advancements of devices will increase the competition among the market players. Many companies are concentrating on new approvals, funding, and development of new products related to cardiac assist device because of the increase in implantable procedures. For instance, Teleflex announced FDA approval for intra-aortic balloon pump in 2017. The AC3 Optimus device delivers intra-aortic balloon pump therapy to assist in pumping blood.


In October 2018, FDA approved HeartMate 3 left ventricular assist device developed by Abbott, as a destination therapy for patients with advanced heart failure. In January 2018, Canada regulatory body issued a Class IV License with conditions to HeartMate 3 Left Ventricular Assist System (LVAS) developed by Thoratec Corporation. BiVACOR Pty Ltd is developing a rotary Total Artificial Heart (TAH) device and its initiative is funded by OneVentures, a venture capital firm and the Federal Government of Australia. In addition, other leading vendors are focusing in investing huge on research and development activities to develop new products to obtain high share in the market.

Key vendors:

• Abbott Laboratories
• Berlin Heart GmbH
• Maquet GmbH (Getinge AB)
• ReliantHeart, Inc.
• SynCardia Systems, LLC
• ABIOMED, Inc.
• BiVACOR, Inc.
• Medtronic plc
• XENIOS AG (Fresenius Medical Care AG & Co. KGaA)
• Teleflex Incorporated
• Carmat SA
• Calon Cardio-Technology Ltd.
• LivaNova, PLC

Key competitive facts –

• The market is highly competitive with all the players competing to gain market share. Intense competition, rapid advancements in technology, frequent changes in government policies, and the prices of devices are some of the key factors that confront the market.
• The requirement of high initial investment, implementation, and maintenance cost in the market are also limiting the entry of new players.
Benefits – The report provides complete details about the current and forecast market size of every type of cardiac assist devices and market values by region. Through this report, the key stakeholders in the cardiac assist devices ecosystem can also know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives towards the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals and to analyze before investing or expanding the business in this market.

Key Takeaways:


• Understanding the potential market opportunity with precise market size and forecast data
• Detailed market analysis focusing on the growth of cardiac assist devices industry
• Factors influencing the growth of cardiac assist devices market
• In-depth competitive analysis of dominant and pureplay vendors
• Prediction analysis of cardiac assist devices industry in both developed and developing regions
• Key insights related to major segments of the cardiac assist devices market
• Latest market trend analysis impacting the buying behavior of the consumers


"

Read More

"Table of Contents
1 INDUSTRY OUTLOOK 8
1.1 Industry Overview 8
1.1.1 Geography 8
1.1.2 Medical Technologies 9
1.1.3 Industry Trends 11
1.2 Total Addressable Market 12
2 Report Outline 13
2.1 Report Scope 13
2.2 Report Summary 13
2.3 Research Methodology 14
2.4 Report Assumptions 14
3 Market Snapshot 16
3.1 Market Definition – Infoholic Research 16
3.2 Device Benefits 16
3.3 Segmented Addressable Market (SAM) 16
3.4 Trends of the Cardiac Assist Devices Market 17
3.5 Related Markets 18
3.5.1 Interventional Cardiology 18
3.5.2 Angioplasty 18
3.5.3 Stents 18
4 Market Outlook 20
4.1 Reimbursement Codes 20
4.2 Regulatory Status 23
4.3 Clinical Trials 24
4.4 Market Segmentation 25
4.5 PEST Analysis 25
4.6 Porter 5(Five) Forces 26
5 Market Characteristics 28
5.1 DRO – Global Cardiac Assist Devices Market Dynamics 28
5.1.1 Drivers 29
5.1.1.1 Increasing incidence of cardiovascular device across the globe 29
5.1.1.2 Lack of heart donors globally 29
5.1.1.3 Increasing aged population 30
5.1.2 Opportunities 30
5.1.2.1 Increase in healthcare spending and demand for improved treatment in developing economies 30
5.1.2.2 Robust pipeline of products 30
5.1.3 Restraints 31
5.1.3.1 High cost of the cardiac assist device 31
5.1.3.2 Stringent regulatory policies 31
5.2 DRO – Impact Analysis 32
5.3 Key Stakeholders 32
6 Products: Market Size and Analysis 34
6.1 Overview 34
6.2 Intra-Aortic Balloon Pumps 35
6.3 Ventricular Assist Devices 36
6.3.1 Left Ventricular Assist Devices 38
6.3.2 Right Ventricular Assist Devices 39
6.3.3 Biventricular Assist Device (BIVAD) 40
6.4 Total Artificial Heart 41
7 Regions: Market Size and Analysis 43
7.1 Overview 43
7.2 North America 44
7.3 Europe 46
7.4 Asia Pacific 47
7.5 Rest of the World 49
8 Competitive Landscape 51
8.1 Overview 51
9 Vendor Profiles 54
9.1 Abbott Laboratories 54
9.1.1 Overview 54
9.1.2 Business Units 57
9.1.3 Geographic Presence 58
9.1.4 Business Focus 59
9.1.5 SWOT Analysis 59
9.1.6 Business Strategies 60
9.2 Berlin Heart GmbH 61
9.2.1 Overview 61
9.2.2 Business Focus 61
9.2.3 SWOT Analysis 62
9.2.4 Business Strategies 62
9.3 Maquet GmbH (Getinge AB) 63
9.3.1 Overview 63
9.3.2 Business Units 65
9.3.3 Geographic Revenue 66
9.3.4 Business Focus 66
9.3.5 SWOT Analysis 67
9.3.6 Business Strategies 67
9.4 ReliantHeart, Inc. 68
9.4.1 Overview 68
9.4.2 Business Focus 69
9.4.3 SWOT Analysis 69
9.4.4 Business Strategies 70
9.5 SynCardia Systems, LLC 70
9.5.1 Overview 70
9.5.2 Business Focus 71
9.5.3 SWOT Analysis 72
9.5.4 Business Strategies 72
10 Companies to Watch For 74
10.1 ABIOMED, Inc. 74
10.1.1 Overview 74
10.2 Medtronic plc 76
10.2.1 Overview 76
10.3 BiVACOR, Inc. 79
10.3.1 Overview 79
10.4 XENIOS AG (Fresenius Medical Care AG & Co. KGaA) 80
10.4.1 Overview 80
10.5 Teleflex Incorporated 81
10.5.1 Overview 81
10.6 Calon Cardio-Technology Ltd. 83
10.6.1 Overview 83
10.7 Carmat SA 84
10.7.1 Overview 84
10.8 LivaNova, PLC 85
10.8.1 Overview 85
11 Annexure 87
11.1 Abbreviations 87


"

Read More

List of Tables & Figures:

TABLE 1 REIMBURSEMENT CODES 20
ICD-10-CM DIAGNOSIS CODES THAT SUPPORT COVERAGE CRITERIA 22
TABLE 2 REGULATORY STATUS OF CARDIAC ASSIST DEVICES 23
TABLE 3 CLINICAL TRIALS 24
TABLE 4 GLOBAL CARDIAC ASSIST DEVICES MARKET REVENUE BY REGIONS, 2018–2025 ($MILLION) 44
TABLE 5 OTHER PROMINENT VENDORS OF CARDIAC ASSIST DEVICES MARKET 52
TABLE 6 ABBOTT LABORATORIES: PRODUCT OFFERINGS 54
TABLE 7 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 54
TABLE 8 BERLIN HEART GMBH: PRODUCT OFFERINGS 61
TABLE 9 BERLIN HEART GMBH: RECENT DEVELOPMENTS 61
TABLE 10 MAQUET GMBH (GETINGE AB): OFFERINGS 63
TABLE 11 MAQUET GMBH (GETINGE AB): RECENT DEVELOPMENTS 63
TABLE 12 RELIANTHEART, INC.: OFFERINGS 68
TABLE 13 RELIANTHEART, INC.: RECENT DEVELOPMENTS 68
TABLE 14 SYNCARDIA SYSTEMS, LLC: PRODUCT OFFERINGS 71
TABLE 15 SYNCARDIA SYSTEMS, LLC: RECENT DEVELOPMENTS 71
TABLE 16 ABIOMED, INC.: SNAPSHOT 74
TABLE 17 ABIOMED, INC.: RECENT DEVELOPMENTS 74
TABLE 18 MEDTRONIC PLC: SNAPSHOT 76
TABLE 19 MEDTRONIC PLC: RECENT DEVELOPMENTS 77
TABLE 20 BIVACOR, INC.: SNAPSHOT 79
TABLE 21 XENIOS AG (FRESENIUS MEDICAL CARE AG & CO. KGAA): SNAPSHOT 80
TABLE 22 XENIOS AG (FRESENIUS MEDICAL CARE AG & CO. KGAA): RECENT DEVELOPMENTS 80
TABLE 23 TELEFLEX INCORPORATED: SNAPSHOT 81
TABLE 24 TELEFLEX INCORPORATED: RECENT DEVELOPMENTS 81
TABLE 25 CALON CARDIO-TECHNOLOGY LTD.: SNAPSHOT 83
TABLE 26 CALON CARDIO-TECHNOLOGY LTD.: RECENT DEVELOPMENTS 84
TABLE 27 CARMAT SA: SNAPSHOT 84
TABLE 28 CARMAT SA: RECENT DEVELOPMENTS 84
TABLE 29 LIVANOVA, PLC.: SNAPSHOT 85
TABLE 30 LIVANOVA, PLC: RECENT DEVELOPMENTS 85


"
"CHARTS
CHART 1 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION 9
CHART 2 RESEARCH METHODOLOGY OF GLOBAL CARDIAC ASSIST DEVICES MARKET 14
CHART 3 GLOBAL CARDIAC ASSIST DEVICES MARKET REVENUE, 2018–2025 ($MILLION) 17
CHART 4 SEGMENTATION OF GLOBAL CARDIAC ASSIST DEVICES MARKET 25
CHART 5 PEST ANALYSIS OF GLOBAL CARDIAC ASSIST DEVICES MARKET 25
CHART 6 PORTER 5 FORCES ON GLOBAL CARDIAC ASSIST DEVICES MARKET 26
CHART 7 MARKET DYNAMICS – DRO ANALYSIS 28
CHART 8 DRO – IMPACT ANALYSIS OF GLOBAL CARDIAC ASSIST DEVICES MARKET 32
CHART 9 KEY STAKEHOLDERS 32
CHART 10 GLOBAL CARDIAC ASSIST DEVICES MARKET BY PRODUCT SEGMENTATION, 2018 (%) 34
CHART 11 GLOBAL CARDIAC ASSIST DEVICES MARKET BY PRODUCT SEGMENTATION, 2025 (%) 35
CHART 12 GLOBAL INTRA-AORTIC BALLOON PUMP MARKET FORECAST, 2018–2025 ($MILLION) 35
CHART 13 GLOBAL VENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018–2025 ($MILLION) 36
CHART 14 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY PRODUCT TYPE SEGMENTATION, 2018 (%) 37
CHART 15 GLOBAL VENTRICULAR ASSIST DEVICES MARKET BY PRODUCT TYPE SEGMENTATION, 2025 (%) 38
CHART 16 GLOBAL LEFT VENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018–2025 ($MILLION) 39
CHART 17 GLOBAL RIGHT VENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018–2025 ($MILLION) 40
CHART 18 GLOBAL BIVENTRICULAR ASSIST DEVICES MARKET FORECAST, 2018–2025 ($MILLION) 41
CHART 19 GLOBAL TOTAL ARTIFICIAL HEART MARKET FORECAST, 2018–2025 ($MILLION) 42
CHART 20 GLOBAL CARDIAC ASSIST DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2018 (%) 43
CHART 21 GLOBAL CARDIAC ASSIST DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2025 (%) 43
CHART 22 CARDIAC ASSIST DEVICES MARKET REVENUE IN NORTH AMERICA, 2018–2025 ($MILLION) 45
CHART 23 CARDIAC ASSIST DEVICES MARKET REVENUE IN EUROPE, 2018–2025 ($MILLION) 47
CHART 24 CARDIAC ASSIST DEVICES MARKET REVENUE IN ASIA PACIFIC, 2018–2025 ($MILLION) 49
CHART 25 CARDIAC ASSIST DEVICES MARKET REVENUE IN REST OF THE WORLD, 2018–2025 ($MILLION) 50
CHART 26 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT 56
CHART 27 ABBOTT LABORATORIES: BUSINESS UNITS 57
CHART 28 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE 58
CHART 29 ABBOTT LABORATORIES: SWOT ANALYSIS 59
CHART 30 BERLIN HEART GMBH: SWOT ANALYSIS 62
CHART 31 MAQUET GMBH (GETINGE AB): OVERVIEW SNAPSHOT 64
CHART 32 MAQUET GMBH (GETINGE AB): BUSINESS UNITS REVENUE 65
CHART 33 MAQUET GMBH (GETINGE AB): GEOGRAPHICAL REVENUE 66
CHART 34 MAQUET GMBH (GETINGE GROUP): SWOT ANALYSIS 67
CHART 35 RELIANTHEART, INC.: SWOT ANALYSIS 69
CHART 36 SYNCARDIA SYSTEMS, LLC: SWOT ANALYSIS 72

 

"

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$2750
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$3500
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$4500
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)

RELATED REPORTS

Global Hemodynamic Monitors Market Professional Survey Report 2019
Global Hemodynamic Monitors Market Professional Survey Report 2019

Global Hemodynamic Monitors Market Professional Survey Report 2019

120 Pages
Type: Report
Code: QYRE-Auto-20G322
Wed Nov 06 00:00:00 UTC 2019

Add to Cart

Global Transcatheter Mitral Valve Repair and Replacement Market Professional Survey Report 2019
Global Transcatheter Mitral Valve Repair and Replacement Market Professional Survey Report 2019

Global Transcatheter Mitral Valve Repair and Replacement Market Professional Survey Report 2019

120 Pages
Type: Report
Code: QYRE-Auto-25Z296
Wed Nov 06 00:00:00 UTC 2019

Add to Cart

Global Cholesterol Screening Cholesterol Lab Testing Market Professional Survey Report 2019
Global Cholesterol Screening Cholesterol Lab Testing Market Professional Survey Report 2019

Global Cholesterol Screening/ Cholesterol Lab Testing Market Professional Survey Report 2019

120 Pages
Type: Report
Code: QYRE-Auto-8F646
Wed Nov 06 00:00:00 UTC 2019

Add to Cart

Global Calcium Heparin Market Professional Survey Report 2019
Global Calcium Heparin Market Professional Survey Report 2019

Global Calcium Heparin Market Professional Survey Report 2019

120 Pages
Type: Report
Code: QYRE-Auto-24X336
Wed Nov 06 00:00:00 UTC 2019

Add to Cart

0 Items
X
No items in the cart.
$0.0